Skip to content

A randomized controlled trial for modified Wu-Zhu-Yu Decoction integrated with acupuncture at Shaoyang acupoint in the treatment of migraine with cold and stasis obstructing meridian

A randomized controlled trial for modified Wu-Zhu-Yu Decoction integrated with acupuncture at Shaoyang acupoint in the treatment of migraine with cold and stasis obstructing meridian

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019502
Enrollment
Unknown
Registered
2018-11-15
Start date
2018-11-30
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

migraine

Interventions

Group 1:modified Wu-Zhu-Yu decoction companied with acupuncture at shaoyang acupoint
Group 2:modified Wu-Zhu-Yu decoction

Sponsors

Beijing Shunyi Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. diagnosed as the typical migraine with or without aura; 2. first migraine attack under the age of 50 years old; 3. history of migraine for more than 1 year; 4. 6 or more attacks monthly during the last 3 months; 5. aged between 18 and 65 years; 6. do not attend similar clinical trial in recent month

Exclusion criteria

Exclusion criteria: 1. 10 times or more analgesic attacking monthly; 2. alcohol or other drugs abuse; 3. sever primary diseases of cardiovascular system, cerebrovascular system, liver, kidney and hematopoietic system; 4. psychopath; 5. allergic to this drug or fainting during acupuncture treatment; 6. pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
frequency of migraine attack;

Secondary

MeasureTime frame
days of migraine attack;pain intensity of migraine;total time of migraine;Quality of life;

Countries

China

Contacts

Public ContactHongweil Liu

Beijing Shunyi Hospital of Traditional Chinese Medicine

hongweil_dr@163.com+86 18810379565

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026